Ingersoll-Rand (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 20, 2025, 10:52 pm

Quick Insight

Ingersoll-Rand (India) Ltd, with a market cap of ₹11,360 Cr. and a P/E ratio of 42.9, reflects strong investor confidence despite a relatively high valuation. The company's impressive ROE of 45.0% and ROCE of 60.0% indicate efficient capital utilization and robust profitability. With a healthy OPM of 26% and a solid ICR of 153.65x, Ingersoll-Rand exhibits strong operational efficiency and financial health. The high P/BV ratio of 19.92x suggests a premium attached to its book value. However, the low FII ownership at 2.31% might be an area for potential growth and diversification. In conclusion, Ingersoll-Rand presents a compelling investment opportunity backed by strong financial performance and operational excellence.

Competitors of Ingersoll-Rand (India) Ltd

All Competitor Stocks of Ingersoll-Rand (India) Ltd

Quarterly Result

Last Updated: August 20, 2025, 9:00 am

Below is a detailed analysis of the quarterly data for Ingersoll-Rand (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 315.00 Cr.. The value appears to be declining and may need further review. It has decreased from 322.00 Cr. (Mar 2025) to 315.00 Cr., marking a decrease of 7.00 Cr..
• For Expenses, as of Jun 2025, the value is 241.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 239.00 Cr. (Mar 2025) to 241.00 Cr., marking an increase of 2.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 74.00 Cr.. The value appears to be declining and may need further review. It has decreased from 83.00 Cr. (Mar 2025) to 74.00 Cr., marking a decrease of 9.00 Cr..
• For OPM %, as of Jun 2025, the value is 24.00%. The value appears to be declining and may need further review. It has decreased from 26.00% (Mar 2025) to 24.00%, marking a decrease of 2.00%.
• For Other Income, as of Jun 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 80.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Mar 2025) to 80.00 Cr., marking a decrease of 10.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 59.00 Cr.. The value appears to be declining and may need further review. It has decreased from 68.00 Cr. (Mar 2025) to 59.00 Cr., marking a decrease of 9.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 18.68. The value appears to be declining and may need further review. It has decreased from 21.43 (Mar 2025) to 18.68, marking a decrease of 2.75.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:37 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 11, 2025, 4:36 pm

Below is a detailed analysis of the balance sheet data for Ingersoll-Rand (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 32.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 32.00 Cr..
• For Reserves, as of Mar 2025, the value is 578.00 Cr.. The value appears strong and on an upward trend. It has increased from 549.00 Cr. (Mar 2024) to 578.00 Cr., marking an increase of 29.00 Cr..
• For Borrowings, as of Mar 2025, the value is 11.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 6.00 Cr. (Mar 2024) to 11.00 Cr., marking an increase of 5.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 312.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 266.00 Cr. (Mar 2024) to 312.00 Cr., marking an increase of 46.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 932.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 852.00 Cr. (Mar 2024) to 932.00 Cr., marking an increase of 80.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 137.00 Cr.. The value appears to be declining and may need further review. It has decreased from 140.00 Cr. (Mar 2024) to 137.00 Cr., marking a decrease of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 50.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2024) to 50.00 Cr., marking an increase of 44.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 745.00 Cr.. The value appears strong and on an upward trend. It has increased from 706.00 Cr. (Mar 2024) to 745.00 Cr., marking an increase of 39.00 Cr..
• For Total Assets, as of Mar 2025, the value is 932.00 Cr.. The value appears strong and on an upward trend. It has increased from 852.00 Cr. (Mar 2024) to 932.00 Cr., marking an increase of 80.00 Cr..

Notably, the Reserves (578.00 Cr.) exceed the Borrowings (11.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Ingersoll-Rand (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 70.45. This value is within the healthy range. It has increased from 57.86 (Mar 23) to 70.45, marking an increase of 12.59.
• For Diluted EPS (Rs.), as of Mar 24, the value is 70.45. This value is within the healthy range. It has increased from 57.86 (Mar 23) to 70.45, marking an increase of 12.59.
• For Cash EPS (Rs.), as of Mar 24, the value is 76.06. This value is within the healthy range. It has increased from 63.03 (Mar 23) to 76.06, marking an increase of 13.03.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 183.82. It has increased from 183.11 (Mar 23) to 183.82, marking an increase of 0.71.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 183.82. It has increased from 183.11 (Mar 23) to 183.82, marking an increase of 0.71.
• For Dividend / Share (Rs.), as of Mar 24, the value is 70.00. This value exceeds the healthy maximum of 3. It has increased from 50.00 (Mar 23) to 70.00, marking an increase of 20.00.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 384.47. It has increased from 364.54 (Mar 23) to 384.47, marking an increase of 19.93.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 100.69. This value is within the healthy range. It has increased from 83.96 (Mar 23) to 100.69, marking an increase of 16.73.
• For PBIT / Share (Rs.), as of Mar 24, the value is 95.07. This value is within the healthy range. It has increased from 78.78 (Mar 23) to 95.07, marking an increase of 16.29.
• For PBT / Share (Rs.), as of Mar 24, the value is 94.41. This value is within the healthy range. It has increased from 78.02 (Mar 23) to 94.41, marking an increase of 16.39.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 70.45. This value is within the healthy range. It has increased from 57.85 (Mar 23) to 70.45, marking an increase of 12.60.
• For PBDIT Margin (%), as of Mar 24, the value is 26.18. This value is within the healthy range. It has increased from 23.03 (Mar 23) to 26.18, marking an increase of 3.15.
• For PBIT Margin (%), as of Mar 24, the value is 24.72. This value exceeds the healthy maximum of 20. It has increased from 21.61 (Mar 23) to 24.72, marking an increase of 3.11.
• For PBT Margin (%), as of Mar 24, the value is 24.55. This value is within the healthy range. It has increased from 21.40 (Mar 23) to 24.55, marking an increase of 3.15.
• For Net Profit Margin (%), as of Mar 24, the value is 18.32. This value exceeds the healthy maximum of 10. It has increased from 15.87 (Mar 23) to 18.32, marking an increase of 2.45.
• For Return on Networth / Equity (%), as of Mar 24, the value is 38.32. This value is within the healthy range. It has increased from 31.59 (Mar 23) to 38.32, marking an increase of 6.73.
• For Return on Capital Employeed (%), as of Mar 24, the value is 50.66. This value is within the healthy range. It has increased from 42.66 (Mar 23) to 50.66, marking an increase of 8.00.
• For Return On Assets (%), as of Mar 24, the value is 26.09. This value is within the healthy range. It has increased from 21.25 (Mar 23) to 26.09, marking an increase of 4.84.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.42. It has increased from 1.34 (Mar 23) to 1.42, marking an increase of 0.08.
• For Current Ratio (X), as of Mar 24, the value is 2.57. This value is within the healthy range. It has decreased from 2.61 (Mar 23) to 2.57, marking a decrease of 0.04.
• For Quick Ratio (X), as of Mar 24, the value is 1.89. This value is within the healthy range. It has decreased from 2.03 (Mar 23) to 1.89, marking a decrease of 0.14.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.99. This value is below the healthy minimum of 4. It has decreased from 4.13 (Mar 23) to 3.99, marking a decrease of 0.14.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 99.36. This value exceeds the healthy maximum of 50. It has increased from 86.42 (Mar 23) to 99.36, marking an increase of 12.94.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 92.02. This value exceeds the healthy maximum of 50. It has increased from 79.32 (Mar 23) to 92.02, marking an increase of 12.70.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.64. This value is below the healthy minimum of 40. It has decreased from 13.58 (Mar 23) to 0.64, marking a decrease of 12.94.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 7.98. This value is below the healthy minimum of 40. It has decreased from 20.68 (Mar 23) to 7.98, marking a decrease of 12.70.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 153.65. This value is within the healthy range. It has increased from 110.12 (Mar 23) to 153.65, marking an increase of 43.53.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 108.51. This value is within the healthy range. It has increased from 76.88 (Mar 23) to 108.51, marking an increase of 31.63.
• For Enterprise Value (Cr.), as of Mar 24, the value is 11,334.60. It has increased from 7,969.39 (Mar 23) to 11,334.60, marking an increase of 3,365.21.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 9.34. This value exceeds the healthy maximum of 3. It has increased from 6.93 (Mar 23) to 9.34, marking an increase of 2.41.
• For EV / EBITDA (X), as of Mar 24, the value is 35.66. This value exceeds the healthy maximum of 15. It has increased from 30.07 (Mar 23) to 35.66, marking an increase of 5.59.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 9.52. This value exceeds the healthy maximum of 3. It has increased from 7.16 (Mar 23) to 9.52, marking an increase of 2.36.
• For Retention Ratios (%), as of Mar 24, the value is 0.63. This value is below the healthy minimum of 30. It has decreased from 13.57 (Mar 23) to 0.63, marking a decrease of 12.94.
• For Price / BV (X), as of Mar 24, the value is 19.92. This value exceeds the healthy maximum of 3. It has increased from 14.26 (Mar 23) to 19.92, marking an increase of 5.66.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 9.52. This value exceeds the healthy maximum of 3. It has increased from 7.16 (Mar 23) to 9.52, marking an increase of 2.36.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 23) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness